Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas

The European Respiratory Journal
A M JonesA K Webb

Abstract

Burkholderia cepacia is a plant phytogen and is known as a hardy and versatile organism. Over the past two decades it has emerged as a pathogen in the cystic fibrosis (CF) community, with devastating effects. Pulmonary colonisation can lead to an accelerated decline in lung function. In some cases, it causes a rapid and progressive pneumonic illness termed "cepacia syndrome", which is untreatable and fatal. B. cepacia is inherently resistant to multiple antibiotics and highly transmissible and virulent strains have been identified. CF patients colonised with the organism have to be segregated from their peers to try to prevent cross-infection. However, the pathogenicity of B. cepacia is not limited to CF. Other groups, such as individuals with chronic granulomatous disease and immunocompromised patients are vulnerable and it has caused disease in healthy individuals. However, the agricultural and petrochemical industries are attempting to exploit properties of B. cepacia for use as a biopesticide and biodegradation agent. This article provides an up to date review of clinically based literature on the Burkholderia cepacia complex, highlighting clinical management issues for both cystic fibrosis and non-cystic fibrosis patients....Continue Reading

Citations

Oct 15, 2011·Applied Microbiology and Biotechnology·Silvia BazziniGiovanna Riccardi
Dec 21, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G MarioniA Staffieri
Mar 22, 2003·Research in Microbiology·Peter VandammeJohn R W Govan
May 6, 2003·Journal of Bacteriology·Vasu PunjA M Chakrabarty
Jun 7, 2003·Journal of Clinical Microbiology·Tom CoenyeEshwar Mahenthiralingam
Sep 6, 2003·Journal of Clinical Microbiology·Mónica V CunhaIsabel Sá-Correia
Oct 11, 2003·American Journal of Respiratory and Critical Care Medicine·Marita GilljamD Elizabeth Tullis
Mar 12, 2011·Diagnostic Microbiology and Infectious Disease·Chun-Hsing LiaoPo-Ren Hsueh
Mar 9, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Aeshna AminArvind Kumar Bansal
May 31, 2008·The Journal of Hospital Infection·C-J YangM-S Huang
May 1, 2007·Clinics in Chest Medicine·Jonathan B Zuckerman, David B Seder
Jul 14, 2007·Cellular Microbiology·Silvia A SousaGerd Döring
Aug 13, 2015·Indian Journal of Pediatrics·Liz Mary PaulSuchitra Shenoy
Nov 26, 2003·Biochemical and Biophysical Research Communications·Leonilde M MoreiraIsabel Sá-Correia
Sep 12, 2015·Case Reports in Infectious Diseases·Naomi Hauser, Jose Orsini
Mar 1, 2007·FEMS Microbiology Reviews·Peter van BaarlenBart P H J Thomma
Feb 16, 2008·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Megan W FranceAndrew M Jones
Sep 27, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Anju T PetersRaymond G Slavin
Dec 24, 2013·Clinical Radiology·M Y NgE Smith
Apr 10, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Pascal C MorelXavier Bertrand
Jun 20, 2008·Innate Immunity·Anthony De SoyzaAntonio Molinaro
Nov 21, 2007·Organic & Biomolecular Chemistry·Régis FauréRené Roy
Apr 15, 2004·Journal of Korean Medical Science·Heung-Bum OhSun-Young Oh
Apr 25, 2019·International Journal of Molecular Sciences·Viola Camilla ScoffoneSilvia Buroni
May 16, 2003·Journal of Medical Microbiology·Ross LangleyJohn R W Govan
Jun 17, 2003·International Journal of Systematic and Evolutionary Microbiology·Vincent RamissePhilippe Normand
Jun 24, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thomas J CremerSusheela Tridandapani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.